

HIV trial
Immune response may be harnessed to control HIV, RIO study shows
New antibody therapies could offer alternative to current treatments.
Immune response may be harnessed to control HIV, RIO study shows
New antibody therapies could offer alternative to current treatments.
AI research may identify risk of emergency hospitalisation from admin data
Generative AI research using a country's administrative health records may identify people at risk of imminent emergency, enabling early intervention.
COVID-19 linked to increase in biomarkers for abnormal brain proteins
Researchers have uncovered a link between COVID-19 and blood markers linked to faulty proteins in the brain.
Feature
Healthcare staff celebrated at Imperial research event
NHS staff across north-west London showcased their research work and projects at an event to celebrate their achievements.
AI model can predict health risks, including early death, from ECGs
A new AI model can predict patients’ risk of developing and worsening disease, and even their risk of early death, using an electrocardiogram (ECG).
Innovative trial will use psilocybin to target relapse in opioid addiction
Imperial researchers will explore the potential for psilocybin therapy in drug recovery as part of a landmark trial.
Imperial to be part of new London Advanced Therapies Treatment Centre
Imperial College London to join Advanced Therapies Treatment Centre (ATTC) Network with institutions in the capital.
Weight-loss drug may slow Alzheimer’s decline
A drug prescribed for diabetes and weight loss has been shown to reduce brain shrinkage in Alzheimer’s patients by almost 50%.
How high-fibre foods make people feel fuller
Researchers at Imperial College London have discovered how foods with a higher fibre content keep us feeling more satiated.